BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD

Overview

BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering ALOGLIPTIN BENZOATE; BENDAMUSTINE HCl; CANAGLIFLOZIN HEMIHYDRATE; EMPAGLIFLOZIN; IVABRADINE HYDROCHLORIDE; LINAGLIPTIN.

API / Drug Master Files

BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• EMPAGLIFLOZINActive2015-10-23
• CANAGLIFLOZIN HEMIHYDRATEActive2015-06-10
• SAXAGLIPTIN HCLActive2015-05-11
• SOFOSBUVIRActive2014-12-24
• IVABRADINE HYDROCHLORIDEActive2014-09-29
• BENDAMUSTINE HClActive2014-07-27
• LINAGLIPTINActive2014-06-26
• SITAGLIPTIN PHOSPHATE MONOHYDRATEActive2014-05-29
• ALOGLIPTIN BENZOATEActive2014-04-24
• VILDAGLIPTINActive2014-04-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.